Highlights
- EPS (TTM)
- -$4.35
- Total Revenue (TTM)
- $14.75M
- Gross Profit (TTM)
- $7.89M
- EBITDA (TTM)
- -$9.70M
- Year Range
- $2.73 - $13.50
- Target Price
- $6.00
- ROA (TTM)
- -51.88%
- ROE (TTM)
- -115.59%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Ekso Bionics Holdings Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Ekso Bionics Holdings Inc (EKSO) has returned 23.26% so far this year and 76.18% over the past 12 months. Over the last ten years, EKSO has returned -37.40% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
Ekso Bionics Holdings Inc
- 1D
- 6.18%
- 1M
- 5.03%
- YTD
- 23.26%
- 6M
- 107.60%
- 1Y
- 76.18%
- 3Y*
- -24.50%
- 5Y*
- -35.48%
- 10Y*
- -37.40%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jan 16, 2014, EKSO's average daily return is +0.02%, while the average monthly return is +0.22%. At this rate, your investment would double in approximately 26.3 years.
Historically, 37% of months were positive and 63% were negative. The best month was Feb 2014 with a return of +144.9%, while the worst month was May 2017 at -63.9%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 12 months.
On a daily basis, EKSO closed higher 43% of trading days. The best single day was Jun 25, 2020 with a return of +135.3%, while the worst single day was Aug 9, 2016 at -36.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.69% | 16.55% | 5.03% | 23.26% | |||||||||
| 2025 | -11.74% | -2.53% | -23.21% | 17.62% | -36.29% | -27.37% | 5.78% | 7.76% | 36.80% | 5.07% | -12.24% | 82.66% | -5.57% |
| 2024 | -8.40% | -17.03% | -28.42% | -8.82% | -7.26% | -8.26% | -0.47% | 14.29% | -3.33% | -26.21% | -18.81% | -12.23% | -75.60% |
| 2023 | 42.02% | -15.38% | 15.38% | -9.70% | -9.40% | 5.93% | -18.88% | -22.39% | -18.58% | 48.70% | 60.55% | 42.86% | 110.08% |
| 2022 | -8.68% | 7.44% | 11.15% | -21.45% | -16.30% | -13.16% | 6.67% | 33.52% | -33.62% | 5.77% | -36.97% | 14.42% | -55.09% |
| 2021 | 42.90% | -18.38% | -13.71% | -7.46% | -0.53% | -3.17% | -11.64% | -1.65% | -3.35% | -12.99% | -19.15% | -18.46% | -56.77% |
Benchmark Metrics
Ekso Bionics Holdings Inc has an annualized alpha of -4.54%, beta of 0.74, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since January 17, 2014.
- This stock participated in 178.68% of S&P 500 Index downside but only -40.96% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -4.54%
- Beta
- 0.74
- R²
- 0.01
- Upside Capture
- -40.96%
- Downside Capture
- 178.68%
Return for Risk
Risk / Return Rank
EKSO ranks 66 for risk / return — better than 66% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Ekso Bionics Holdings Inc (EKSO) and compare them to a chosen benchmark (S&P 500 Index).
| EKSO | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.58 | 0.90 | -0.31 |
Sortino ratioReturn per unit of downside risk | 1.92 | 1.39 | +0.53 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.21 | +0.03 |
Calmar ratioReturn relative to maximum drawdown | 0.99 | 1.40 | -0.41 |
Martin ratioReturn relative to average drawdown | 1.70 | 6.61 | -4.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore EKSO risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Ekso Bionics Holdings Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Ekso Bionics Holdings Inc was 99.98%, occurring on Jun 23, 2025. The portfolio has not yet recovered.
The current Ekso Bionics Holdings Inc drawdown is 99.91%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.98% | Feb 25, 2014 | 2849 | Jun 23, 2025 | — | — | — |
| -11.32% | Jan 23, 2014 | 8 | Feb 3, 2014 | 3 | Feb 6, 2014 | 11 |
| -10.38% | Feb 10, 2014 | 5 | Feb 14, 2014 | 2 | Feb 19, 2014 | 7 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Ekso Bionics Holdings Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Ekso Bionics Holdings Inc is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for EKSO relative to other companies in the Medical Instruments & Supplies industry. Currently, EKSO has a P/S ratio of 1.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |